Hosted on MSN28d
Aclaris Therapeutics Unveils Promising Data on ATI-2138, a Novel Dual ITK/JAK3 InhibitorAccording to Dr. Joseph Monahan, Chief Scientific Officer of Aclaris Therapeutics, “This publication provides important clinical and non-clinical evidence of the potential for ATI-2138 to be a ...
Tom Monahan covered stories such as the Hartford Civic Center roof collapse, Hurricane Gloria and the Whalers' departure from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results